Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Gandara

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Oncology (Williston Park, N.Y.)|April 17, 2001
Gemcitabine in combination with new platinum compounds: an updateD R Gandara, M J Edelman, P N Lara, et al.
Anti-Cancer Drugs|May 9, 2001
Neoadjuvant therapy for non-small cell lung cancerD R Gandara, P N Lara, Z Goldberg, et al.
Cancer|October 15, 1984
Upper abdominal computerized tomography scanning in staging non-small cell lung carcinomaG S Chapman, D Kumar, J Redmond, et al.
Anticancer Research|July 1, 1989
Evaluation of cisplatin dose intensity: current status and future prospectsD R Gandara, E A Perez, W A Phillips, et al.
Seminars in Oncology|April 14, 1999
Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancerC J Langer, D R Gandara, P Calvert, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Pharmacokinetics of cisplatin in patients receiving interleukin-2-containing treatment regimensD R Gandara, E A Perez, A Denham, et al.
Cancer|September 15, 1984
Prolymphocytic leukemia. Serial responses to therapyJ F Swift, H G Wold, D R Gandara, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Treatment of refractory chronic lymphocytic leukemia with prednimustine: a phase II study using strict response criteriaD R Gandara, C B George, C A Ries, et al.
Cancer|December 1, 1987
Fatal bleomycin toxicity from a low cumulative dose in a patient with renal insufficiencyB F McLeod, H J Lawrence, D W Smith, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group studyD R Gandara, M J Edelman, J J Crowley, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Oncology (Williston Park, N.Y.)|April 17, 2001
Gemcitabine in combination with new platinum compounds: an updateD R Gandara, M J Edelman, P N Lara, et al.
Anti-Cancer Drugs|May 9, 2001
Neoadjuvant therapy for non-small cell lung cancerD R Gandara, P N Lara, Z Goldberg, et al.
Cancer|October 15, 1984
Upper abdominal computerized tomography scanning in staging non-small cell lung carcinomaG S Chapman, D Kumar, J Redmond, et al.
Anticancer Research|July 1, 1989
Evaluation of cisplatin dose intensity: current status and future prospectsD R Gandara, E A Perez, W A Phillips, et al.
Seminars in Oncology|April 14, 1999
Gemcitabine and carboplatin in combination: an update of phase I and phase II studies in non-small cell lung cancerC J Langer, D R Gandara, P Calvert, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Pharmacokinetics of cisplatin in patients receiving interleukin-2-containing treatment regimensD R Gandara, E A Perez, A Denham, et al.
Cancer|September 15, 1984
Prolymphocytic leukemia. Serial responses to therapyJ F Swift, H G Wold, D R Gandara, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Treatment of refractory chronic lymphocytic leukemia with prednimustine: a phase II study using strict response criteriaD R Gandara, C B George, C A Ries, et al.
Cancer|December 1, 1987
Fatal bleomycin toxicity from a low cumulative dose in a patient with renal insufficiencyB F McLeod, H J Lawrence, D W Smith, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group studyD R Gandara, M J Edelman, J J Crowley, et al.
Pageof 9